Cannabismarketcap

AdvisorShares Pure Cannabis ETF (YOLO) Stock Analysis — October 2026

Last updated: Oct 29, 2026NYSE: YOLOCannabis ETF

Executive Summary

AdvisorShares Pure Cannabis ETF (NYSE: YOLO) is a cannabis etf company currently priced at $2.56 per share with a market capitalization of $30.4M. The stock trades on the NYSE exchange in the United States market, and is positioned as a small-cap player within the cannabis sector.

Price
$2.56
-0.78%
Market Cap
$30.4M
NYSE
Revenue (TTM)
—
— YoY
P/S Ratio
—
EV/Rev —

Key Takeaways

Market Capitalization

AdvisorShares Pure Cannabis ETF has a market cap of $30.4M, making it a small-cap cannabis company listed on the NYSE.

52-Week Price Position

At $2.56, the stock trades at 8% of its 52-week range ($2.39 – $4.53). Trading near yearly lows could present value for contrarian investors.

AdvisorShares Pure Cannabis ETF Company Overview

AdvisorShares Pure Cannabis ETF (NYSE: YOLO) is a cannabis exchange-traded fund (ETF) currently trading at $2.56 per share with a market capitalization of $30.4M. The stock declined +0.78% in the most recent trading session on volume of 23.3K shares. AdvisorShares Pure Cannabis ETF is headquartered in the United States and employs approximately 0 people. As a participant in the cannabis exchange-traded fund (etf) segment, the company operates within one of the most dynamic and rapidly evolving sectors of the North American economy.

Trailing twelve-month (TTM) revenue for AdvisorShares Pure Cannabis ETF is not reported in our data. Revenue trends in the cannabis industry are closely watched by analysts, as the sector continues to navigate pricing compression, oversupply dynamics in certain markets, and the ongoing burden of IRS Section 280E, which prevents cannabis businesses from deducting ordinary business expenses at the federal level.

Financial Analysis

Revenue (TTM)
—
Gross Margin
—
Revenue Growth
—
Cash on Hand
—
Total Debt
—
Cash Runway
—

Trailing twelve-month revenue for AdvisorShares Pure Cannabis ETF is not reported in our data.

Revenue momentum is a critical metric for cannabis companies, as the industry continues to evolve through shifts in consumer demand, regulatory changes, and competitive dynamics. Year-over-year revenue growth for AdvisorShares Pure Cannabis ETF is not reported in our data. The cannabis industry's profitability dynamics are heavily influenced by IRS Section 280E, which prevents plant-touching operators from deducting ordinary business expenses for federal income tax purposes, effectively creating tax rates that can exceed 70% of gross profit.

Valuation Analysis

A price-to-sales (P/S) ratio for AdvisorShares Pure Cannabis ETF is not available in our data. Cannabis stock valuations have compressed significantly from their 2021 highs, and current multiples reflect a more mature market environment where investors demand clear paths to profitability. For context, the broader ETF sector contains 6 publicly traded companies tracked by Cannabismarketcap, and AdvisorShares Pure Cannabis ETF's valuation should be considered within the context of its specific growth profile and competitive positioning.

ETF Sector Peer Comparison

CompanyPriceMarket CapP/SEV/RevGross MarginRev Growth
YOLO$2.56$30.4M————
MSOS$4.05$781.2M————
MJ$22.48$113.0M————
CNBS$23.48$75.3M————

Balance Sheet Deep Dive

Cash & Equivalents
—
Total Debt
—
Net Cash / Debt Position
—

Cash and debt figures for AdvisorShares Pure Cannabis ETF are not reported in our data. Access to capital remains a persistent challenge for cannabis companies, particularly plant-touching operators that are excluded from traditional banking services and institutional lending. Many cannabis companies have turned to sale-leaseback transactions, private placements, and at-the-market (ATM) equity offerings to fund operations. AdvisorShares Pure Cannabis ETF's balance sheet should be evaluated with these industry-specific constraints in mind.

Cash and total debt for AdvisorShares Pure Cannabis ETF are not reported in our data, so we cannot assess its net cash or net debt position.

The company's annual share dilution rate is not reported in our data. With 11.7M shares currently outstanding, any additional equity issuance directly impacts per-share metrics including earnings per share, book value per share, and ownership percentage.

Cannabis ETF Sector Context

Within the Cannabis Exchange-Traded Fund (ETF) sector, AdvisorShares Pure Cannabis ETF ranks #4 out of 6 companies by market capitalization, commanding a 2.9% share of the sector's total market cap of $1.03B. Cannabis ETFs are exchange-traded funds that provide diversified exposure to a basket of cannabis-related stocks. They allow investors to gain broad cannabis sector exposure without selecting individual companies. The largest company in the sector by market cap is AdvisorShares Pure US Cannabis ETF (MSOS) at $781.2M, followed by ETFMG Alternative Harvest ETF (MJ) at $113.0M.

Trailing twelve-month revenue for AdvisorShares Pure Cannabis ETF is not reported in our data, so it is not ranked by revenue.

AdvisorShares Pure Cannabis ETF occupies a mid-tier position within the Cannabis Exchange-Traded Fund (ETF) sector. The company's market capitalization of $30.4M reflects the market's assessment of its growth potential and risk profile relative to the 5 other tracked peers. Investors should evaluate AdvisorShares Pure Cannabis ETF alongside its direct sector competitors to understand relative value and operational momentum.

Historical Price Performance

52-Week Range8% from low
$2.39
$4.53
Current: $2.56

AdvisorShares Pure Cannabis ETF (YOLO) currently trades at $2.56, which places the stock at approximately 8% of its 52-week trading range. Over the past twelve months, YOLO has traded as high as $4.53 and as low as $2.39, representing a 89.3% spread between the yearly high and low. The current price sits 43.4% below the 52-week high and 7.1% above the 52-week low. This range provides important context for understanding the stock's recent volatility and where current levels fall within the broader price history.

In the most recent trading session, YOLO fell +0.78% from a previous close of $2.58 to $2.56, on volume of 23.3K shares. This negative session is within the range of normal daily fluctuations for cannabis stocks, which tend to exhibit higher volatility than the broader equity market. The stock has 11,720,000 shares outstanding, giving it a fully diluted market capitalization that investors should factor into their analysis alongside the current $30.4M market cap figure.

Cannabis stocks have historically exhibited significant price volatility driven by regulatory developments, earnings surprises, and shifts in market sentiment toward the sector. YOLO is trading in the lower portion of its 52-week range, which could represent a value opportunity for contrarian investors, or may reflect deteriorating fundamentals that warrant caution. Historical price levels should be considered alongside fundamental data — including revenue trends, margin improvement, and balance sheet health — to form a complete investment thesis.

Investment Thesis

A balanced framework for evaluating AdvisorShares Pure Cannabis ETF (YOLO) as a potential investment, considering both the upside catalysts and downside risks based on the company's current financial data and industry positioning.

Bull Case
1

Revenue stabilization and potential for operational improvements could reignite top-line growth. Even modest gains in market share or pricing power could meaningfully impact the company's financial trajectory and investor sentiment toward YOLO.

2

Potential for margin recovery as the cannabis market matures and pricing stabilizes. Regulatory reform — particularly the rescheduling of cannabis and elimination of Section 280E tax burdens — could dramatically improve the gross margin profile for AdvisorShares Pure Cannabis ETF and the broader industry.

3

Federal cannabis reform — including potential rescheduling, banking access via the SAFE Banking Act, or eventual descheduling — would be a transformative catalyst for AdvisorShares Pure Cannabis ETF and the entire cannabis sector. Any legislative progress could unlock institutional capital flows, improve banking access, and eliminate the Section 280E tax burden that suppresses profitability industry-wide.

Bear Case
1

Intensifying competition from both legal operators and the persistent illicit market could pressure AdvisorShares Pure Cannabis ETF's revenue growth and margins. The cannabis industry remains highly fragmented, and market share gains are becoming increasingly difficult as more states award licenses and new competitors enter the market.

2

Cannabis companies continue to face restricted access to traditional banking, institutional capital, and federal bankruptcy protections. These structural disadvantages increase the cost of capital and limit AdvisorShares Pure Cannabis ETF's financial flexibility compared to companies in federally legal industries, creating an uneven competitive landscape.

3

Regulatory uncertainty remains the single largest risk for AdvisorShares Pure Cannabis ETF and all cannabis investments. Federal prohibition in the United States creates ongoing challenges including Section 280E tax burdens, limited interstate commerce, and the risk of enforcement actions. State-level regulatory changes, licensing moratoriums, and social equity requirements add additional layers of unpredictability that can materially impact the company's operations and growth plans.

Risk Factors

Key risks that investors should consider before investing in AdvisorShares Pure Cannabis ETF (YOLO). This is not an exhaustive list, and investors should conduct their own due diligence.

Regulatory & Legal Risk

Cannabis remains a Schedule I controlled substance under federal law, creating fundamental legal uncertainty for AdvisorShares Pure Cannabis ETF and all plant-touching cannabis operators. Changes in federal enforcement policy, state regulatory frameworks, or local ordinances could materially impact the company's operations, licensing, and financial performance. The evolving patchwork of state regulations creates compliance complexity and limits the ability to operate across state lines.

Section 280E Tax Burden

Under IRS Section 280E, cannabis businesses are prohibited from deducting ordinary business expenses for federal income tax purposes. This effectively results in tax rates that can exceed 70% of gross profit for plant-touching operators, significantly reducing cash flow available for reinvestment and debt service. While potential rescheduling could eliminate this burden, the timeline and outcome remain uncertain, and AdvisorShares Pure Cannabis ETF's profitability metrics should be evaluated with this tax overhang in mind.

Market & Competition Risk

The cannabis industry faces pricing pressure from oversupply in mature markets, competition from the illicit market (which avoids regulatory costs and taxation), and evolving consumer preferences. AdvisorShares Pure Cannabis ETF competes for market share against both established operators and well-funded new entrants. Price compression in key markets has squeezed margins across the industry, and any worsening of these trends could materially impact the company's revenue and profitability outlook.

Frequently Asked Questions

Common questions about AdvisorShares Pure Cannabis ETF (YOLO) stock, answered with real-time data from Cannabismarketcap.

What is AdvisorShares Pure Cannabis ETF's (YOLO) stock price today?

AdvisorShares Pure Cannabis ETF (YOLO) stock is currently trading at $2.56 per share on the NYSE exchange. This represents a daily decline of -0.78% ($0.0200) from the previous closing price of $2.58. Over the past 52 weeks, YOLO has traded between a low of $2.39 and a high of $4.53, placing the current price at approximately -43% from its annual high. The stock has a market capitalization of $30.4M, making it a notable cannabis companies tracked by Cannabismarketcap. AdvisorShares Pure Cannabis ETF operates in the ETF sector, serving the broader cannabis industry.

What is AdvisorShares Pure Cannabis ETF's market capitalization?

AdvisorShares Pure Cannabis ETF (YOLO) has a current market capitalization of $30.4M, calculated by multiplying its 11.7M shares outstanding by the current stock price of $2.56. Market capitalization is a key measure of a company's total equity value as perceived by the public market, and it places AdvisorShares Pure Cannabis ETF among the small-cap cannabis companies tracked on Cannabismarketcap. Investors often use market cap alongside revenue and profitability metrics to assess relative valuation within the cannabis sector.

What are AdvisorShares Pure Cannabis ETF's key financial metrics?

AdvisorShares Pure Cannabis ETF (YOLO) reports several important financial metrics that investors track closely. The company has a market capitalization of $30.4M. Cash and debt figures for AdvisorShares Pure Cannabis ETF are not reported in our data. With 11.7M shares outstanding, investors should consider both the fundamental financial performance and share structure when evaluating YOLO.

What exchange is YOLO listed on?

AdvisorShares Pure Cannabis ETF trades under the ticker symbol YOLO on the NYSE exchange, and the stock is denominated in US dollars (USD). Shares can typically be purchased through most standard brokerage accounts. The company has been publicly listed since 2019-04-18, giving it a track record in the public markets that investors can analyze for long-term trends. The stock sees average daily trading volume of approximately 23.3K shares, which is an important consideration for liquidity and the ability to enter or exit positions without significant price impact.

What sector is AdvisorShares Pure Cannabis ETF in?

AdvisorShares Pure Cannabis ETF is classified as a cannabis exchange-traded fund (ETF), meaning it is an exchange-traded fund that provides diversified exposure to a basket of cannabis-related securities. The ETF sector is a key segment of the cannabis market, and investors often compare companies within the same sector to identify relative outperformers. You can compare YOLO with other ETF stocks on Cannabismarketcap's sector page to see how it ranks on metrics like market cap, revenue, and margins.

How does YOLO compare to other cannabis stocks?

You can compare AdvisorShares Pure Cannabis ETF (YOLO) side-by-side with any cannabis stock on Cannabismarketcap using the dedicated comparison tool. Key comparison metrics include market cap ($30.4M). AdvisorShares Pure Cannabis ETF sits in the ETF sector, so the most relevant peer comparisons would be against other ETF companies, though cross-sector comparisons can also reveal interesting insights about relative valuation. Visit the rankings page to see where YOLO stands across all cannabis companies on metrics like revenue growth, cash position, and employee count (N/A).

What is YOLO's 52-week trading range?

AdvisorShares Pure Cannabis ETF (YOLO) has traded between a 52-week low of $2.39 and a 52-week high of $4.53, with the current price of $2.56 sitting approximately -43% from the annual high. This range represents a spread of $2.14 (89% from low to high), which reflects the volatility the stock has experienced over the past year. The 52-week range is a commonly used technical indicator that helps investors understand whether a stock is trading near the top or bottom of its recent range, and it can inform decisions about entry and exit points. Cannabis stocks in general tend to exhibit higher volatility than broader market indices due to evolving regulations and market sentiment.

How does AdvisorShares Pure Cannabis ETF's valuation compare to cannabis industry peers?

AdvisorShares Pure Cannabis ETF (YOLO) is valued at a market capitalization of $30.4M. In the cannabis industry, valuations can vary significantly depending on sector (MSO, LP, Ancillary, etc.), growth rate, and path to profitability. Investors can use the Cannabismarketcap rankings and comparison tools to benchmark YOLO against specific competitors on valuation multiples, growth rates, and profitability.

Is AdvisorShares Pure Cannabis ETF stock overvalued or undervalued?

Determining whether AdvisorShares Pure Cannabis ETF (YOLO) is overvalued or undervalued requires analyzing multiple valuation metrics in context. The stock is currently trading at $2.56, which is -43% from its 52-week high of $4.53. Investors should consider the broader cannabis industry outlook when forming a valuation opinion. Cannabismarketcap provides all the data needed for a thorough analysis, but this information should not be considered investment advice.

What are the risks of investing in AdvisorShares Pure Cannabis ETF?

Investing in AdvisorShares Pure Cannabis ETF (YOLO) carries several risks that investors should carefully consider. First, the cannabis industry remains federally illegal in the United States, creating regulatory uncertainty that can impact stock prices, banking access, and tax obligations (notably IRC Section 280E). Second, AdvisorShares Pure Cannabis ETF's cash and debt levels are not reported in our data, so investors should check its latest filings for liquidity and dilution risk. Additionally, the stock has shown a 52-week range of $2.39 to $4.53, reflecting meaningful price volatility. As with all cannabis stocks, investors face risks from changing state regulations, competitive pressures, and the evolving legal landscape. This information is for educational purposes only and is not investment advice.

How many shares outstanding does AdvisorShares Pure Cannabis ETF have?

AdvisorShares Pure Cannabis ETF (YOLO) currently has 11.7M shares outstanding, which when multiplied by the current stock price of $2.56 gives the company its market capitalization of $30.4M. Share count is important because all per-share metrics (earnings per share, book value per share, etc.) are directly impacted by changes in shares outstanding. Cannabis companies frequently issue new shares to raise capital, so monitoring dilution trends on Cannabismarketcap is recommended for long-term investors.

Does AdvisorShares Pure Cannabis ETF pay a dividend?

Most cannabis companies, including AdvisorShares Pure Cannabis ETF (YOLO), do not currently pay dividends. The cannabis industry is still in a growth phase, and companies typically reinvest available capital into expanding operations, securing new licenses, building out retail and cultivation infrastructure, and navigating complex regulatory requirements. Additionally, the IRC Section 280E tax burden significantly reduces the free cash flow available for shareholder distributions. Investors in cannabis stocks should generally expect returns to come from capital appreciation rather than dividend income. If AdvisorShares Pure Cannabis ETF initiates a dividend in the future, it would be reported in their SEC filings and reflected on Cannabismarketcap.

How can I research AdvisorShares Pure Cannabis ETF stock before investing?

To research AdvisorShares Pure Cannabis ETF (YOLO) before investing, start with the company overview on Cannabismarketcap, which provides current price ($2.56), market cap ($30.4M), and key financial metrics. Next, review the full financial statements page for quarterly revenue trends, margins, and balance sheet details. Check the analyst ratings page for Wall Street consensus and price targets, and the technical analysis page for chart patterns and momentum indicators. Compare YOLO against sector peers using the comparison tool to understand relative valuation. Review recent news coverage for regulatory developments or corporate events. Finally, read the investment analysis page for a comprehensive deep-dive. Cannabis investing carries unique risks including federal illegality, regulatory uncertainty, and limited banking access — always conduct thorough due diligence before making any investment decision.

What does AdvisorShares Pure Cannabis ETF's market cap of $30.4M mean?

AdvisorShares Pure Cannabis ETF's market capitalization of $30.4M represents the total market value of all its outstanding shares (11.7M shares multiplied by the current stock price of $2.56). Market cap is the primary measure investors use to classify companies by size: small-cap companies (under $100M) like AdvisorShares Pure Cannabis ETF may offer higher growth potential but come with greater risk and lower liquidity. In the cannabis sector, market cap is especially important because it determines index weighting, institutional investment eligibility, and often correlates with the company's operational scale and geographic reach. AdvisorShares Pure Cannabis ETF currently ranks # among cannabis stocks tracked on Cannabismarketcap.

What regulatory risks does AdvisorShares Pure Cannabis ETF face?

AdvisorShares Pure Cannabis ETF (YOLO), like all cannabis companies, faces significant regulatory risks that investors should understand. At the federal level, cannabis remains a Schedule I controlled substance in the United States, which restricts banking access, prevents standard business expense deductions under IRC Section 280E, and creates legal uncertainty. AdvisorShares Pure Cannabis ETF is subject to the evolving regulatory landscape across the jurisdictions where it operates. Potential catalysts include federal rescheduling (which could ease 280E burdens), the SAFE Banking Act (which would improve banking access), and individual state legalization events. Conversely, regulatory setbacks such as license moratoriums, increased enforcement, or unfavorable tax policy changes pose downside risks. Investors should monitor legislative developments closely using Cannabismarketcap's news and legalization tracker.

More YOLO Research & Data

Disclaimer: The information presented on this page is for informational and educational purposes only and does not constitute investment advice, financial advice, trading advice, or any other kind of advice. Cannabismarketcap does not recommend that any security be bought, sold, or held by you. All investments involve risk, and the past performance of a security, industry, sector, market, financial product, trading strategy, or individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. Cannabis stocks carry additional risks including federal illegality, regulatory uncertainty, limited banking access, and high volatility. Always conduct your own research and consider consulting a qualified financial advisor before making investment decisions.